Touchstone International Medical Science Co., Ltd. (SHA:688013)

SHA:688013 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	314.08	272.34	253.6	231.73	213.74	163.34
Other Revenue	0.03	0.03	0.04	0.31	0	0
Revenue	314.11	272.37	253.65	232.03	213.74	163.34
Revenue Growth (YoY)	14.63%	7.38%	9.31%	8.56%	30.85%	-5.45%
Cost of Revenue	118.85	113.64	111.8	99.8	91.27	68.25
Gross Profit	195.27	158.73	141.85	132.23	122.47	95.09
Selling, General & Admin	82.32	74.66	71.9	61.66	62.37	48.47
Research & Development	40.07	35.99	35.32	34.75	29.28	15.37
Other Operating Expenses	1.9	1.79	4.75	2.39	2.13	1.35
Operating Expenses	124.46	112.38	112.27	98.97	94.05	65.27
Operating Income	70.8	46.34	29.58	33.27	28.41	29.82
Interest Expense	-0.28	-0.23	-0.09	-0.16	-	-
Interest & Investment Income	6.08	9.12	8.03	4.76	11.15	2.26
Currency Exchange Gain (Loss)	-0.01	-0.01	2.47	3.94	4	1.8
Other Non Operating Income (Expenses)	10.85	-0.17	1.89	-0.12	-0.06	-0.09
EBT Excluding Unusual Items	87.44	55.06	41.88	41.69	43.51	33.79
Gain (Loss) on Sale of Investments	-0.13	-1.89	4.06	2.09	0.44	0.56
Gain (Loss) on Sale of Assets	-0	-0	0	0.02	0.52	-0
Asset Writedown	-0.01	-	-	-	-	-
Legal Settlements	-	-	-	-	-1.08	-
Other Unusual Items	1.66	1.66	2.01	2.28	2.71	5.85
Pretax Income	88.97	54.83	47.95	46.08	46.09	40.2
Income Tax Expense	7.88	2.94	0.64	2.89	4.67	5.25
Net Income	81.09	51.89	47.31	43.2	41.42	34.95
Net Income to Common	81.09	51.89	47.31	43.2	41.42	34.95
Net Income Growth	42.38%	9.69%	9.53%	4.29%	18.52%	-16.80%
Shares Outstanding (Basic)	79	80	79	80	80	65
Shares Outstanding (Diluted)	81	81	82	82	81	65
Shares Change (YoY)	1.54%	-0.60%	0.09%	0.35%	25.49%	7.85%
EPS (Basic)	1.02	0.65	0.60	0.54	0.52	0.54
EPS (Diluted)	1.00	0.64	0.58	0.53	0.51	0.54
EPS Growth	40.22%	10.35%	9.43%	3.92%	-5.56%	-22.86%
Free Cash Flow	13.45	11.47	64.54	2.73	51.77	34.79
Free Cash Flow Per Share	0.17	0.14	0.79	0.03	0.64	0.54
Dividend Per Share	0.500	1.000	-	0.250	0.200	0.200
Dividend Growth	-	-	-	25.00%	-	-
Gross Margin	62.16%	58.28%	55.92%	56.99%	57.30%	58.22%
Operating Margin	22.54%	17.02%	11.66%	14.34%	13.29%	18.25%
Profit Margin	25.81%	19.05%	18.65%	18.62%	19.38%	21.39%
Free Cash Flow Margin	4.28%	4.21%	25.44%	1.18%	24.22%	21.30%
EBITDA	80.1	55.53	38.63	41.35	35.64	36.36
EBITDA Margin	25.50%	20.39%	15.23%	17.82%	16.67%	22.26%
D&A For EBITDA	9.29	9.19	9.05	8.09	7.22	6.54
EBIT	70.8	46.34	29.58	33.27	28.41	29.82
EBIT Margin	22.54%	17.02%	11.66%	14.34%	13.29%	18.25%
Effective Tax Rate	8.86%	5.36%	1.33%	6.27%	10.14%	13.07%
Revenue as Reported	314.11	272.37	253.65	232.03	213.74	163.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.